Supplementary Materials and Methods, Supplementary Tables 1--4 and Supplementary Figures 1-4 from Preclinical Characterization of an Antibody–Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1–Positive Cells